X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
anti-bacterial agents - pharmacology (5) 5
fosfomycin - pharmacology (5) 5
humans (5) 5
in-vitro activity (5) 5
microbiology (5) 5
anti-bacterial agents - therapeutic use (4) 4
antibiotics (4) 4
fosfomycin (4) 4
greece (4) 4
infectious disease (4) 4
infectious diseases (4) 4
microbial sensitivity tests (4) 4
pharmacology & pharmacy (4) 4
pseudomonas-aeruginosa (4) 4
bacterial infections (3) 3
biochemical phenomena, metabolism, and nutrition (3) 3
drug resistance in microorganisms (3) 3
drug resistance, multiple, bacterial (3) 3
enterobacteriaceae - drug effects (3) 3
escherichia-coli (3) 3
fosfomycin - therapeutic use (3) 3
gram-negative bacteria (3) 3
gram-negative bacterial infections - microbiology (3) 3
health aspects (3) 3
urinary-tract-infections (3) 3
acinetobacter baumannii - drug effects (2) 2
aminoglycosides (2) 2
antimicrobial resistance (2) 2
bacterial pneumonia (2) 2
beta lactamases (2) 2
beta-lactamases (2) 2
care and treatment (2) 2
ciprofloxacin (2) 2
drug therapy (2) 2
enterobacteriaceae infections - microbiology (2) 2
gram-negative bacteria - drug effects (2) 2
gram-negative bacteria - isolation & purification (2) 2
gram-negative bacterial infections - drug therapy (2) 2
hospitals (2) 2
intensive-care units (2) 2
outbreak (2) 2
pneumonia (2) 2
acinetobacter baumannii (1) 1
acinetobacter baumannii - isolation & purification (1) 1
acinetobacter-baumannii (1) 1
acinetobacter-baumannii infections (1) 1
amikacin - pharmacology (1) 1
amikacin - therapeutic use (1) 1
animals (1) 1
antagonism (1) 1
anti-infective agents (1) 1
antibacterial activity (1) 1
antibiotic susceptibility (1) 1
antibiotic-resistance (1) 1
antibiotic-therapy (1) 1
antimicrobial agents (1) 1
antimicrobials (1) 1
bacilli (1) 1
bacteremia (1) 1
bacteria (1) 1
bacteria - drug effects (1) 1
bacterial drug resistance (1) 1
beta-lactam antibiotics (1) 1
burkholderia - drug effects (1) 1
burkholderia - isolation & purification (1) 1
caprolactam (1) 1
case-control studies (1) 1
ceftazidime - pharmacology (1) 1
ceftazidime - therapeutic use (1) 1
cephalosporins (1) 1
cephalosporins - pharmacology (1) 1
ciprofloxacin - pharmacology (1) 1
ciprofloxacin - therapeutic use (1) 1
clinical trials (1) 1
clinical-features (1) 1
cohort studies (1) 1
colonization (1) 1
community (1) 1
cystic fibrosis (1) 1
cystic-fibrosis (1) 1
data processing (1) 1
drug combinations (1) 1
drug resistance (1) 1
drug synergism (1) 1
drug therapy, combination (1) 1
drug-resistance (1) 1
e-coli (1) 1
emergence (1) 1
endocarditis (1) 1
endocarditis, bacterial - drug therapy (1) 1
enterobacteriaceae - isolation & purification (1) 1
enterobacteriaceae infections - drug therapy (1) 1
enterococcus - drug effects (1) 1
enterococcus - isolation & purification (1) 1
esbls (1) 1
extended-spectrum -lactamases (1) 1
extended-spectrum beta-lactamases (1) 1
extendedspectrum b-lactamases (1) 1
fluoroquinolone-resistant (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Antimicrobial Agents, ISSN 0924-8579, 2009, Volume 34, Issue 2, pp. 111 - 120
Abstract The treatment of multidrug-resistant (MDR), extensively drug-resistant or pandrug-resistant non-fermenting Gram-negative bacterial infections... 
Infectious Disease | Metallo-β-lactamases | Cystic fibrosis | Pneumonia | Microbial sensitivity tests | Drug combinations | Bacterial drug resistance | Metallo-beta-lactamases | INFECTIOUS DISEASES | ANTIBIOTIC SUSCEPTIBILITY | INTENSIVE-CARE UNITS | MICROBIOLOGY | SEROTYPE O-12 | ACINETOBACTER-BAUMANNII | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | BETA-LACTAMASES | CYSTIC-FIBROSIS | OUTBREAK | CIPROFLOXACIN | IN-VITRO ACTIVITY | Endocarditis, Bacterial - drug therapy | Pseudomonas aeruginosa - isolation & purification | Fosfomycin - therapeutic use | Fosfomycin - pharmacology | Pseudomonas Infections - drug therapy | Humans | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas aeruginosa - drug effects | Burkholderia - isolation & purification | Drug Synergism | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Animals | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Burkholderia - drug effects | Medical research | Drug resistance in microorganisms | Care and treatment | Bacterial infections | Microbiology | Bacterial pneumonia | Caprolactam | Clinical trials | Aminoglycosides | Fosfomycin | Endocarditis | Medicine, Experimental | Beta lactamases | Drug therapy, Combination | Ciprofloxacin | Health aspects | Index Medicus
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 04/2010, Volume 66, Issue 4, pp. 359 - 368
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2010, Volume 10, Issue 1, p. 43
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S1473-3099(09)70325-1 Byline: Matthew E Falagas (a)(b)(c), Antonia C... 
Drug resistance in microorganisms | Care and treatment | Beta lactamases | Urinary tract infections | Anti-infective agents | Health aspects | Fosfomycin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.